Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APN201 for prevention of radiation-induced dermatitis in breast cancer
NCT01513278Phase 2Completed
- Sponsor
- APEIRON Biologics AG
- Start
- Jan 2012
- Primary completion
- May 2012
- Countries
- 1
01
Overview
A Phase 2 trial of APN201 in radiation-induced dermatitis (RID), sponsored by APEIRON Biologics AG. Started Jan 2012; status: completed.
02
Drugs
APN201
03
Conditions
radiation-induced dermatitis (RID)
Beyond the preview
Go deeper on NCT01513278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01513278.